Lymphoid Malignancies: From Basic Science to Clinical Advances
A special issue of Lymphatics (ISSN 2813-3307).
Deadline for manuscript submissions: 28 February 2027 | Viewed by 110
Special Issue Editor
Interests: hematopoiesis; self-renew; differentiation; hematopoietic cancer; molecular pathway
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lymphoid malignancies, including lymphomas and lymphoid leukemias, represent a heterogeneous group of hematological cancers with diverse biological underpinnings and clinical behaviors. Rapid progress in molecular profiling, targeted therapies, immunotherapeutic strategies, and precision diagnostics has transformed our understanding of these diseases, yet major gaps remain in translating fundamental insights into clinical outcomes. This Special Issue aims to bring together cutting-edge research and comprehensive reviews spanning basic science, translational studies, and clinical advances in lymphoid malignancies.
Topics of interest include, but are not limited to, the following:
- Mechanisms of lymphomagenesis;
- Tumor microenvironment interactions;
- Novel biomarkers;
- Targeted therapies;
- Immune-based therapies;
- Resistance mechanisms;
- Clinical trial outcomes.
We invite original research articles and reviews that deepen our mechanistic understanding and drive innovative therapeutic strategies. This collection will provide a multidisciplinary platform to foster collaboration among scientists and clinicians advancing lymphoid malignancy research.
Dr. Jingxin Zhang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Lymphatics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lymphoid malignancies
- basic science to clinical translation
- immunotherapy
- tumor microenvironment
- precision diagnostics
- novel biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
